Product Development Strategy / Life Cycle Planning

RoadmapOne of the most important tools to help ensure successful product development and commercialization is a well-planned Target Product Profile. A successful TPP development requires an understanding of today’s disease/treatment/market dynamics and as well as how these dynamics will change at the time of launch which is typically several years away. We leverage our proven TPP process to engage appropriate functional areas to effectively address clinical, regulatory and market needs. A key to successful TPP development is to begin early and ensure cross functional participation. This TPP combined with a clinical strategy allows companies to effectively plan and execute product development activities.  In addition to TPP, once the product establishes proof-of-concept, a life cycle plan (LCP) has to be developed so that the full asset value could be maximized during its life cycle.

R&D Portfolio Strategy and Management

A portfolio strategy is a necessity for a Life Sciences company dealing with multiple inline and pipeline assets to ensure optimal positioning combined with effective resource allocation to drive results. Developing the right portfolio strategy is critical to ensure that company goals are achieved. Our streamlined approach allows R&D and Commercial groups to assess gaps in the current portfolio and develop potential options to address these gaps.

With tight R&D budgets and high failure rates in product development, prioritizing product portfolio is critical for any company. An objective process is required to assess, prioritize, and allocate resources across these R&D projects. A portfolio prioritization process/system based on key scientific and commercial metrics is needed to effectively prioritize products. An integrated strategy across R&D, Business Development and Commercial is often required to achieve portfolio goals.